ArticleOncotarget2014

Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor.

Paul Mésange et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.